Health Care/Hospital

CStone Announces Presentation of Preclinical data on a Multi-Specific Antibody-based Therapeutic Candidate CS2006/NM21-1480 at the American Association for Cancer Research (AACR) Annual Meeting 2022

* Results from pharmacokinetic/pharmacodynamic modeling demonstrated that binding affinity optimization of CS2006/NM21-1480 allowed optimal PD-L1 blockade and 4-1BB stimulation concomitantly, at a broad dose range thereby and facilitating dose-finding in the clinic * CS2006/NM21-1480 was effi...

2022-04-13 08:02 1834

JUNIPER BIOLOGICS ACQUIRES CELL-MEDIATED GENE THERAPY TG-C LD FOR TREATMENT OF KNEE OSTEOARTHRITIS

$600 million USD acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients inAsia Pacific, Middle East and Africa  SINGAPORE, April 13, 2022 /PRNewswire/ -- Juniper Biologics, a science-led healthcare company focused on researc...

2022-04-13 07:57 1607

Adge Pharmaceuticals advances its rare disease programs, attends ASCEND 2022 Rett Syndrome National Summit.

MOUNTAIN VIEW, Calif., April 13, 2022 /PRNewswire/ -- Adge Pharmaceuticals ("Adge") continues to advance its rare disease programs in the Rett Syndrome and Osteogenesis imperfecta in support of the regulatory requirements of the US FDA to move its lead asset expeditiously to the clinic. In prepa...

2022-04-13 07:00 953

Cambrex Completes Large-Scale US API Expansion

EAST RUTHERFORD, N.J., April 13, 2022 /PRNewswire/ -- Cambrex announced today the completion of a$50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at itsCharles City, Iowa facility. The startup of the new manufacturing space is the culminat...

2022-04-13 06:50 1069

Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment

ROSCREA, Ireland, April 12, 2022 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal ("GI") disorders, announced today that it has entered into a share subscription agreement with...

2022-04-12 20:00 888

Esaote S.p.A. turns 40 and is confirmed as a leading player in the world market for diagnostic imaging with ultrasound systems, magnetic resonance imaging and information technology for healthcare

GENOA, Italy, April 12, 2022 /PRNewswire/ -- Esaote S.p.A., a leading biomedical company in the diagnostic imaging sector - in the fields of ultrasound, magnetic resonance and Information Technology for health - celebrates forty years of activity.  

2022-04-12 19:00 1090

New Clinical Advisory Board to support PromarkerD global rollout

* Proteomics International establishes world class Clinical Advisory Board promarkerd.com/clinical-advisory-board * Comprises highly-respected physicians specialising in diabetes and kidney disease care fromthe United States, Europe and Austra...

2022-04-12 16:04 824

Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer

MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Australian and US MedTech start-up Nutromics (Nutromics or the Company), a global leader in DNA-based biosensors, today announced that DrAgim Beshiri, most recently Senior Medical Director at Abbott Laboratories, has joined the organisation as ...

2022-04-12 09:28 657

VenusP-Valve(TM) obtains CE marking under MDR and debuts in Europe as China's first valve product

HANGZHOU, China, April 12, 2022 /PRNewswire/ -- On April 8th, 2022, VenusP-Valve TM, Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, received CE marking under the Medical Devices Regulation (MDR) to be marketed inEurope. Designed to treat patie...

2022-04-12 09:20 625

Strong Growth in Digital Health Powers MediHeroes, A Cross Border B2B Medical Platform

SINGAPORE, April 12, 2022 /PRNewswire/ --  MediHeroes will launch a "Verify Before Buy" platform created especially for suppliers, buyers and service providers in the MedTech industry onApril 15, 2022. A transformative industry platform, MediHeroes helps buyers and sellers save months to years ...

2022-04-12 09:00 819

ProstACT Update: TARGET Study Ethics Approval

MELBOURNE, Australia, April 12, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its ProstACT TARGET Phase II clinical trial of the Company's prostate cancer antibody therapy candidate TLX591 (177Lu-DOTA-rosopatamab), in patients experiencing a fir...

2022-04-12 07:47 824

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA

SHANGHAI, April 11, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of HANSIZHUANG (serplulimab), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with chemotherapy for the first-line tr...

2022-04-11 22:07 1372

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas MOUNTAIN VIEW, Calif., April 11, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation com...

2022-04-11 19:00 1093

Frost & Sullivan Hails Sphere Fluidics for Enabling Efficient, Faster, and More Cost-effective Single-cell Analysis with Its Microfluidic Platforms

The flexible and easy-to-use microfluidic platforms easily adapt to customers' unique research needs, boost throughput and efficiency, and enhance customers' single-cell research capabilities. SAN ANTONIO, April 11, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the European microfluidi...

2022-04-11 18:00 423

APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial

BOSTON, April 11, 2022 /PRNewswire/ -- APRINOIA Therapeutics announces today that the U.S. Food and Drug Administration (FDA) has granted a may proceed authorization for its novel therapeutic anti-tau monoclonal antibody, APNmAb005, allowing the company to test and evaluate its safety in healthy ...

2022-04-11 18:00 1161

Singapore-based women's healthcare company marks its first Financial Times ranking

Making its debut on the fourth annual Financial Times ranking of 500 of Asia-Pacific's high-growth companies, INEX Innovate - the pioneering healthcare technology company targeting women's health - is one of only 20 healthcare companies listed in the prestigious line up. SINGAPORE, April 11, 202...

2022-04-11 17:21 768

Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou

TAIZHOU, China, April 11, 2022 /PRNewswire/ -- The board of directors of Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group",Stock code:2179.HK) is pleased to announce that, on April 9, 2022, the Company has received the European Union (EU) Qualified Pe...

2022-04-11 16:05 1376

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

HONG KONG, April 11, 2022 /PRNewswire/ -- Clinical researchers from The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) have identified for the first time distinct gut microbiome profiles associated with post-acute COVID-19 syndrome, more commonly known as "long COVID"....

2022-04-11 12:35 1395

Mental Health Matters: Calling for Better Insurance Coverage

HONG KONG, April 11, 2022 /PRNewswire/ -- Mental health is one of the most neglected areas of health inHong Kong and the ongoing pandemic has further worsened the status. High stress levels and increasing prevalence of mental health issues are prompting consumers to take action, and seek assist...

2022-04-11 11:00 1076

Honeywell Teams with AstraZeneca to Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant

* Next-generation inhaler will use Honeywell's Solstice® Air to reduce greenhouse gas emissions of propellant by up to 99.9 percent vs current inhaler propellant * Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through in...

2022-04-11 09:00 962
1 ... 203204205206207208209 ... 551

Week's Top Stories